欢迎访问西安瑞禧生物技术有限公司官方网站

图片名

全国订购热线:
18966759382

首页 > 新闻资讯 > 市场活动

市场活动
行业新闻 市场活动 技术资讯

Inosinic acid-13C10,15N4 dilithium,5'-IMP-13C10,15N4 dilithium; IMP-13C10,15N4 dilithium; Inosine 5'-(dihydrogen phosphate-13C10,15N4 dilithium「同位素标记抑制剂」

作者:瑞禧生物 发布时间:2025-06-16 09:13:53 次浏览

生物活性:Inosinic acid-13C10,15N4 dilithium (5'-IMP-13C10,15N4 (dilithium); IMP-13C10,15N4 (dilithium); Inosine 5'-(dihydrogen phosphate)-13C10,15N4 (dilithium)) is 13C- and 15N-labeled Inosinic acid (HY-108213). Inosinic acid is an endogenous metabolite. Inosinic acid is used as umami tastant, or as the dietary supplement to improve the yield and meat quality of pigs[1].
体外研究(In Vitro):氢、碳和其他元素的稳定重同位素已被纳入药物分子中,主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注,因为它可能影响药物的药代动力学和代谢谱[1]。
瑞禧生物 has not independently confirmed the accuracy of these methods. They are for reference only.
分子量:373.97
Formula:13C10H11Li215N4O8P
非标记 CAS:131-99-7
性状:液体
颜色:Colorless to light yellow
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Solution, -20°C, 2 years
纯度 & 产品资料
纯度: ≥99.0%
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-220.
 [Content Brief]